Recent Finacing
Recent Raise
Achaogen is a biopharmaceutical company developing small-molecule, broad‑spectrum antibiotics (lead candidate ACHN-490) and advancing clinical and preclinical programs targeting multi‑drug‑resistant bacterial infections.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors